Medicine's Endgame

The past, present, and future of cell-based therapy

Medicine's Endgame The past, present, and future of cell-based therapy Oct 31, 2023 119 21 10 Share Welcome to the 1,563 newly Not Boring people who have joined us since our last Tuesday essay! If you haven’t subscribed, join 214,602 smart, curious folks by subscribing here: Subscribe Today’s Not Boring is brought to you by… Percent Private Credit: It’s a popular asset class these days. You’ve maybe noticed an increase in headlines in WSJ, FT, etc. It’s a multi-trillion dollar asset class that’s grown 800% since 2006. But what is it? Pretty simple actually: Private credit is when non-banks len

saved by

• Proby Shandilya

related reading

• Going Founder Mode On Cancer - by Elliot Hershbergcenturyofbio.com
• The blood cancer that became solvableworksinprogress.news
• Medical breakthroughs in 2025 - by Saloni Dattaniscientificdiscovery.dev
• Models of Lifepress.asimov.com
• 癌症治療的海豹特種部隊 淺談CAR-T細胞治療法::台灣癌症基金會canceraway.org.tw
• Immunotherapy for Cancer - NCIcancer.gov
• Arc Institute’s first virtual cell model: <span style="font-variant: small-caps">S<span style="font-weight: bolder">tate</span></span> | Arc Institutearcinstitute.org
• 16 Open Problems in Engineering Biology | Andreessen Horowitza16z.com
• Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designationmed.stanford.edu
• Pearl Freier on X: "Cell & gene therapies were 2.5x more likely to receive FDA approval after entering Phase 1 than other drug types according to research by the NEWDIGs initiative at Tufts Medical Center h/t @DrPHanley & @alliancerm . @NatRevDrugDisc paper below 1/n https://t.co/DN4k7qWrAt" / Xx.com
• Teaching an old dog new tricks: next-generation CAR T cells | British Journal of Cancernature.com
• Immunotherapy in pediatric malignancies: current status and future perspectives - PMCncbi.nlm.nih.gov